Bady 2012 (M‐GBM).
Study characteristics | ||
Study design | Cohort | |
Study setting | Setting: Neurosurgery Departments of Rennes and Angers University Hospitals Country: France Dates: NR |
|
Selection of participants | Cases from an external dataset (Etcheverry 2010). Prospectively collected samples from people with newly diagnosed GBM | |
Participant characteristics | Sample size: 50 (deaths: NR) Age: median 57.5, SD NR; range 26–80 years Sex: 51% men KPS: median 78.6, range 40–100 |
|
Tumour characteristics | GBM: 100% First diagnosis: 100% Biopsy: NR; subtotal resection: NR; total resection: NR IDH1 wild‐type: NR; IDH2 wild‐type: NR |
|
Treatment regimen | Stupp protocol | |
MGMT promoter methylation tests implemented | PSQ, bead array | |
Dates and follow‐up | Timing of MGMT assessment: at diagnosis Start time for follow‐up: NR; follow‐up: median NR; range NR |
|
Notes |